Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Laura Bertoccini, Diego Bailetti, SUMMER Study in Diabetes Group, Raffaella Buzzetti, Maria Gisella Cavallo, Massimiliano Copetti, Efisio Cossu, Paola D'Angelo, Salvatore De Cosmo, Lazzaro Di Mauro, Frida Leonetti, Susanna Morano, Lelio Morviducci, Nicola Napoli, Sabrina Prudente, Giuseppe Pugliese, Vincenzo Trischitta, Marco Giorgio Baroni
Published Oct 9, 2018 · Vol. 9, No. 79 · pp. 34911-34918
Raphael Hohlfeld, Sabine Brandt, Anja Bernhardt, Xenia Gorny, Daniel Schindele, Burkhard Jandrig, Martin Schostak, Berend Isermann, Jonathan A. Lindquist, Peter R. Mertens
Published Apr 10, 2018 · Vol. 9, No. 27 · pp. 19039-19049